Akums gets DCGI approval to launch Lobeglitazone for diabetes treatment in India
It offers a number of advantages including a higher safety profile, higher effectiveness in lower dosage, lower risk of…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.